(Q44029787)

29 November 2017

title

The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease (English)

1 reference

29 November 2017

0 references

0 references

2

1 reference

29 November 2017

3

A Jennifer Morton

1 reference

29 November 2017

Miriam A Hickey

1

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Journal of Neurochemistry

29 November 2017

published in

1 reference

29 November 2017

volume

81

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

46-59

1 reference

Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

D-amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Dopamine and cognitive functioning: brain imaging findings in Huntington's disease and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Replicating Huntington's disease phenotype in experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Structural insights into the molecular mechanism of Ca(2+)-dependent exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Striatal transplantation in a transgenic mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Neuronal cell death in Huntington's disease: a potential role for dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Role of dopamine D-1 and D-2 receptors in the ventral striatum in the turning behaviour of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Levodopa and Huntington's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Modification of seizure activity by electrical stimulation. II. Motor seizure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Diabetes mellitus: stress, neurochemistry and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Of mice and men: solving the molecular mysteries of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Feeding behavior in dopamine-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00804.X

10.1046/J.1471-4159.2002.00804.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference